Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2007
12/26/2007EP1869045A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases
12/26/2007EP1869044A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases
12/26/2007EP1869043A2 Pyrazolopyridine-1,4-diamines and analogs thereof
12/26/2007EP1869041A1 Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
12/26/2007EP1869040A1 Dna-pk inhibitors
12/26/2007EP1869039A2 Process for preparing bicyclic compounds
12/26/2007EP1869038A1 Substituted 5,6,7,8-tetrahydro-imidazoý1,2-a¨pyridin-2-ylamine compounds and their use for producing drugs
12/26/2007EP1869037A1 Heterobicylic inhibitors of hvc
12/26/2007EP1869036A1 Substituted 1,5-naphthyridine azolidinones as cdk inhibitors
12/26/2007EP1869035A2 Novel forms of tiotropium bromide and processes for preparation thereof
12/26/2007EP1869033A1 Novel enantiomers and their use as monoamine neurotransmitter re-uptake inhibitors
12/26/2007EP1869032A1 Pyrimidine derivatives for use as anticancer agents
12/26/2007EP1869031A1 Thiadiazole substituted coumarin derivatives and their use as leukotriene biosynthesis inhibitor
12/26/2007EP1869030A1 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
12/26/2007EP1869029A1 An oxindole oxazolidinone as antibacterial agent
12/26/2007EP1869028A1 Pyrimidines as igf-i inhibitors
12/26/2007EP1869027A2 Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors
12/26/2007EP1869024A1 New tricyclic angiotensin ii agonists
12/26/2007EP1869023A1 New tricyclic angiotensin ii agonists
12/26/2007EP1869022A1 Naphthalamide derivatives having antiproliferative activity
12/26/2007EP1869021A1 Dna-pk inhibitors
12/26/2007EP1869020A1 HETEROARYL UREA DERIVATIVES USEFUL FOR INHIBITING CHKl
12/26/2007EP1869019A1 Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors
12/26/2007EP1869018A1 3-triazolylthioalkyl-3-azabicyclo (3 - 1 - o) hexanes and their use as dopamine d3 receptor ligands
12/26/2007EP1869017A1 3- (1,2,4-triazol-3ylalkyl) azabriclo (3.1.0) hexane derivatives as modulators of dopamine d3 receptors
12/26/2007EP1869016A1 Imidazolo-5-yl-2-anilo-pyrimidines as agents for the inhibition of cell proliferation
12/26/2007EP1869013A1 Substituted chroman derivatives, method for the production and the use thereof in the form of antiphlogistics
12/26/2007EP1869012A1 Substituted benzylimidazoles useful for the treatment of inflammatory diseases
12/26/2007EP1869011A2 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
12/26/2007EP1869010A1 3-sulfonylamino-pyrrolidine-2-one derivatives as factor xa inhibitors
12/26/2007EP1869009A1 New bicyclic angiotensin ii agonists
12/26/2007EP1869008A1 Inhibitors of prolyl endopeptidase
12/26/2007EP1869006A1 Pyrimidindione derivatives as prokineticin 2 receptor antagonists
12/26/2007EP1869004A1 Substituted carboxylic acid derivatives for the treatment of diabetes and lipid disorders, their preparation and use
12/26/2007EP1869003A1 Indazoles as glucocorticoid receptor ligands
12/26/2007EP1869002A1 Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments
12/26/2007EP1869001A1 Substituted tetrahydroisochinolines as mmp inhibitors, related production method and use as medicine
12/26/2007EP1869000A1 Cyclopentapyridine and tetrahydroquinoline derivatives
12/26/2007EP1868999A1 Pyridine-3-carboxamide derivatives as cb1 inverse agonists
12/26/2007EP1868997A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
12/26/2007EP1868994A1 Sulfonylpyrroles as histone deacetylase inhibitors
12/26/2007EP1868993A1 New crystalline atorvastatin hemicalcium salt polymorph form
12/26/2007EP1868991A1 Histamine h3 receptor agents, preparation and therapeutic uses
12/26/2007EP1868990A2 Novel heterocyclic derivatives
12/26/2007EP1868989A2 Inhibitors of neurotrypsin and determination thereof
12/26/2007EP1868986A1 Tetrahydronaphthalene derivatives method for the production and the use thereof in the form of antiphlogistics
12/26/2007EP1868985A2 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
12/26/2007EP1868984A2 Benzoic acid ester compounds, compositions, uses and methods related thereto
12/26/2007EP1868982A2 Compounds that stimulate glucose utilization and methods of use
12/26/2007EP1868685A2 11ß-HYDROXYSTEROID DEHYDROGENASES
12/26/2007EP1868649A2 Elimination of heterogeneous or mixed cell population in tumors
12/26/2007EP1868633A2 Compositions and methods for the inhibition of dishevelled proteins
12/26/2007EP1868628A2 Compounds, compositions and methods for the treatment of poxvirus infections
12/26/2007EP1868620A1 Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
12/26/2007EP1868619A1 Use of macrolides for treating intestinal inflammation
12/26/2007EP1868618A2 Topical compositions comprising several mono- and/or oligosaccharides for treating skin diseases of warm blood hair coated animals.
12/26/2007EP1868617A1 Combination of a silicon containing component and a hormone
12/26/2007EP1868615A2 Modulation of telomere length in telomerase positive cells and cancer therapy
12/26/2007EP1868614A2 Dosage regimen for the treatment of a traumatic brain injury with progesterone
12/26/2007EP1868613A2 Polymorphs of 3-o-(3',3'-dimethylsuccinyl) betulinic acid di-n-methyl-d-glucamine
12/26/2007EP1868612A2 Novel compounds
12/26/2007EP1868611A2 Novel compounds
12/26/2007EP1868609A2 Prokineticin 1 receptor
12/26/2007EP1868608A2 Method for administration of capecitabine
12/26/2007EP1868607A2 Isoqunoline compounds and methods of use thereof
12/26/2007EP1868606A2 Use of nk-3 receptor antagonists for the treatment of nausea and vomiting
12/26/2007EP1868605A2 Phenyl and pyridyl lta4h modulators
12/26/2007EP1868604A2 Regulation of protein synthesis by inhibition of eif4e-eif4g interaction
12/26/2007EP1868603A1 DERIVATIVES OF Ý6,7-DIHYDRO-5HIMIDAZO Ýl,2-ALPHA¨IMIDAZOLE-3-SULFONYL¨-AZETEDINE-CARBOXYLIC ACIDS, ESTERS AND AMIDES AND USE THEREOF AS ANTI-INFLAMMATORY AGENTS
12/26/2007EP1868602A1 Pharmacological treatment for sleep apnea
12/26/2007EP1868601A1 Mitotic kinesin inhibitors
12/26/2007EP1868600A1 Spirocyclic cyclohexane derivatives for use in the treatment of substance dependency
12/26/2007EP1868599A1 Antitumor combination comprising substituted acryloyl distamycin derivatives and antibodies inhibiting growth factors or their receptors
12/26/2007EP1868598A2 A new dosing regimen for ion channel modulating compounds for treating acute atrial fibrillation in a human
12/26/2007EP1868597A1 Therapeutic use of nefopam and analogues thereof
12/26/2007EP1868596A1 Use of lactobacillus rhamnosus gg in combination with a long chain polyunsaturated fatty acid for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant
12/26/2007EP1868595A2 Compounds for the treatment of metabolic disorders
12/26/2007EP1868594A1 Ganglionic blocking agents for the treatment of epithelial diseases
12/26/2007EP1868593A2 Improved methods of and compositions for the prevention of anxiety, substance abuse, and dependence
12/26/2007EP1868592A2 Treatment of intestinal conditions by a compound which causes rna interference
12/26/2007EP1868590A2 Method of increasing testosterone and related steroid concentrations in women
12/26/2007EP1868587A2 Pharmaceutical formulations comprising fenofibric acid and/or its salts
12/26/2007EP1868586A1 Anti-inflammatory formulation
12/26/2007EP1868585A2 Abuse resistant capsules
12/26/2007EP1868584A1 Dosage forms of risedronate
12/26/2007EP1868581A1 Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs
12/26/2007EP1868579A1 Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
12/26/2007EP1868578A2 Nanoparticulate corticosteroid and antihistamine formulations
12/26/2007EP1868577A1 Lacidipine particles
12/26/2007EP1868576A2 Injectable compositions of nanoparticulate immunosuppressive compounds
12/26/2007EP1868570A2 Methods and systems for operating an aerosol generator
12/26/2007EP1868569A1 Liquid aqueous dosage forms for sub-lingual or nasal applications of active agents with amino groups
12/26/2007EP1868454A2 A method and composition for nutritionally improving glucose control and insulin action
12/26/2007EP1868437A1 Method of treating or preventing bone deterioration or osteoporosis
12/26/2007EP1868435A2 Combinations, methods and compositions for treating cancer
12/26/2007EP1868434A2 Beta-lactamylalkanoic acids for treating premenstrual disorders
12/26/2007EP1868432A2 Methods for treating anxiety related disorders
12/26/2007EP1799214B1 Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
12/26/2007EP1778193B1 Sustained release pharmaceutical particulate composition comprising venlafaxine
12/26/2007EP1761536B1 Novel 2-benzylaminodihydropteridinones, method for producing them and use thereof as drugs
1 ... 3445 3446 3447 3448 3449 3450 3451 3452 3453 3454 3455 3456 3457 3458 3459 3460 3461 3462 3463 3464 3465 ... 7860